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ABSTRACT 
Objective: To determine the differences between human immuno- 
deficiency virus (HIV-infected and non-HIV-infected patients 
with pneumococcal bacteremia. 
Methods: The demographics, clinical findings, and hospital 
course of 194 adult cases of pneumococcal bacteremia were 
retrospectively reviewed. 
Results: All but six patients were African-American and 41% 
had HIV infection. The HIV-infected patients were younger (37 
vs. 51 years, P < 0.0001) and had higher pneumococcal vac- 
cination rate (13% vs. I%, P = 0.0006); 58% of the patients 
under 40 years of age had HIV infection. The HIV-infected 
patients had lower leukocyte count and serum albumin and 
higher arterial pH and oxygenation. The recurrence rate of 
pneumococcal bacteremia was higher in the HIV-infected 
patients (8.5% vs 1.8%, P = 0.0565). Chest radiograph find- 
ings, disease severity, length of hospital stay, complication, and 
case fatality rates were similar between the HIV-infected and 
non-HIV-infected patients, 
Conclusions: The overall hospital course of HIV-infected patients 
with pneumococcal bacteremia is similar to that of non-HIV- 
infected patients, despite some clinical differences. 
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Pneumococcal infection causes significant morbidity and 
mortality, especially in certain risk groups.A recent com- 
munity-based study has shown a rise in the incidence of 
pneumococcal bacteremia.l The highest reported annual 
incidence of pneumococcal bacteremia is 207 per 
100,000 population, in the White Mountain Apache Native 
Indians.’ The annual incidence of pneumococcal bac- 
teremia is calculated to be as high as 940 per 100,000 
patients with acquired immunodeficiency syndrome 
(AIDS).3 The present study aims to describe the differ- 
ences in clinical presentation, hospital course, and out- 
come between human immunodeficiency virus 
(HIV)-infected and non-HIV-infected patients with pneu- 
mococcal bacteremia. 
PATIENTS AND METHODS 
This study was a retrospective chart review conducted at 
Howard University Hospital, a 500-bed inner-city teaching 
hospital located in Washington, DC.The hospital’s patients 
are predominantly African-American, of low socioeco- 
nomic status.Testing for HIV antibody both by enzyme- 
linked immunosorbent assay (ELISA) and Western blot 
was available to patients since April 1985. In the lo-year 
period fromApril 1985 to April 1995,393 cases of pneu- 
mococcal bacteremia were identified from microbiology 
logs. Excluding 71 children under 16 years of age and 
128 adults whose HIV status was unknown, 194 cases of 
pneumococcal bacteremia in 184 patients with known 
HIV status were included in this study. For the purpose 
of this study each case was considered as one patient. 
Data collected included patients’ age, sex, race, risk 
factors for pneumococcal infection, status of pneumo- 
coccal vaccination, initial vital signs, laboratory values, 
source of bacteremia, and in-hospital complications as 
previously described.* In an earlier study, a severity grad- 
ing system was developed, which showed that older age, 
lower mean arterial pressure, lower temperature, higher 
respiratory rate, and lower leukocyte count were associ- 
ated with increased mortality in patients with pneumo- 
coccal bacteremia.* This system was used in the present 
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study to categorize each patient’s severity of illness as 
mild, moderate, or severe. Conditions that indicated AIDS 
were defmed according to the 1993 revised Centers for 
Disease Control and Prevention (CDC) criteria.5 
All means are expressed with standard deviation. For 
comparison between groups, unpaired Student’s t-test 
was used for normally distributed continuous variables, 
Mann-Whitney U test for abnormally distributed contin- 
uous variables; cm-square test for nominal variables; and 
Fisher’s exact test for nominal variables when any one cell 
of a 2 X 2 table contained less than five members. All 
statistical analyses were performed on Abacus Concepts, 
StatView software, version 4.5 (Abacus Concepts, Inc., 
Berkeley, CA).A P-value of less than 0.05 was considered 
significant. 
RESULTS 
Forty-one percent (79/194) of the patients included in 
the study had HIV infection and 115 were HIV negative. 
The demographic data of the patients, their pneumo- 
coccal vaccination status, and the place of acquisition 
and source of bacteremia are listed in Table 1. Fifty-one 
(58%) of the 88 patients under 40 years of age had HIV 
infection. The common risk factors for pneumococcal 
infection in patients without HIV infection were alcohol 
abuse (n = 50) chronic obstructive pulmonary disease 
(COPD) (n = 15) and malignancy (n = 13). Seven (6%) 
of the 115 patients without HIV infection and 37 (47%) 
of the 79 patients with HIV infection were injection drug 
users. Sixteen patients with HN infection had a history 
of alcohol abuse. Risk factors for HIV infection included 
injection drug use (n = 31) homosexuality (n = 26) het- 
erosexual contact (n = S), blood transfusion (n = l), 
homosexuality and injection drug use (n = 6) hetero- 
sexual contact and blood transfusion (n = 3) and uniden- 
tified (n = 4). Thirty (33%) of the 91 patients who 
developed pneumococcal bacteremia in the first 5 years 
of the study period had HIV infection compared to 49 
(48%) of 103 patients in the second 5-year period (P = 
0.0388). 
The initial vital signs, selected laboratory values, and 
chest roentgenogram findings were available in 76 
patients with HIV and 111 patients without HIV infection. 
The differences in these values between the two groups 
are listed in Table 2. Four percent of the HIV-infected 
patients had a temperature less than 36.l”C at presenta- 
tion compared to 7% of the non-HIV-infected patients 
(P = 0.5294). Seventy-one percent of the HIV-infected 
patients had a temperature higher than 37.8”C at pre- 
sentation compared to 61% of the non-HIV-infected 
patients (P = 0.1538). Sixteen percent of the HIV-infected 
patients had a white blood cell count (WBC) count less 
than 3.5 X 103/mm3 at presentation compared to 7% of 
the non-HIV-infected patients (P = 0.0653). Fifty percent 
Table 1. Differences in Demographics, 
Pneumococcal Vaccination Status, Place of Acquisition, 
and Source of Pneumococcal Bacteremia 
between Patients with and without HIV infection 
HIV Non-HIV 
n = 79 (%) n= 115 P-Value 
Age 37.0 i 8.8 51.2 I 19.5 < 0.0001* 
Sex 0.6932+ 
Male 53 (67) 74 (64) 
Female 26 41 
Race 023422+ 
Black 77 (97) 111 (97) 
White 1 1 
Hispanic 1 2 
Asian 
Pneumococcal vaccination 1 i (13) : 0) 0.0006x 
Place of acquisition 0.0810* 
Community 79 (100) 110 (96) 
Hospital 0 5 
Source of bacteremia 0.6888’ 
Lungs 71 (90) 105 (91) 
Meninges 3 2 
Intra-abdominal 0 1 
Unidentified 5 7 
*Student’s t-test; +Chi-square test; *Fisher’s exact test. 
of the HIV-infected patients had a WBC count higher than 
10 X 103/mm3 at presentation compared to 59% of the 
non-HIV-infected patients (P = 0.2202)The disease sever- 
ity was mild in 54%, moderate in 39%, and severe in 7% 
of the HIV-infected patients compared to 44%, 45%, and 
11% respectively of the non-HIV-infected patients (P = 
0.3353). 
Two episodes of pneumococcal bacteremia were 
seen in each of two patients without HIV infection com- 
pared to two episodes in each of four, and three episodes 
in each of two patients with HIV infection in the study 
period.The recurrence rate of pneumococcal bacteremia 
was 8.5% (6/71) in patients with HIV infection compared 
to 1.8% (2/l 13) in those without HIV infection (P = 
O.O565).The median duration of hospital stay was 13 days 
for both groups (P = 0.9419).The 32% (25/79) intensive 
care unit (ICU) admission rate for the HIV-infected 
patients was lower than the 50% (57/115) rate for the 
non-HIV-patients (P = 0.0130). In-hospital complication 
rates were available in 187 patients and are listed inTable 
3.Thirty-four (45%) of 76 patients with HIV infection had 
at least one of the listed complications compared to 60 
(54%) of 111 patients without HIV infection (P = 0.2 107). 
The in-hospital case fatality rate was 25% @O/79) for 
patients with HIV infection compared to 31% (36/l 15) for 
patients without HIV infection (P = 0.3658)The time of 
death following bacteremia and causes of death were not 
significantly different between the two groups (Table 4). 
Forty-two (53%) of the 79 patients with HIV infection 
had AIDS-indicator conditions by the time of the pneu- 
mococcal bacteremia. There were no significant differ- 
ences in age, initial vital signs, initial arterial blood gas 
values, and chest roentgenogram findings between 
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Table 2. Differences in Initial Vital Signs and Laboratory Values between Patients with and without HIV Infection 
H/V Non-HIV 
n = 76 n= 171 
Mean arterial pressure (mm Hg) 83.9 z 15.6 88.2 -t- 19.1 
Temperature (“C) 38.5 f 1.3 38.1 i 1.3 
Pulse (/min) 111.9 + 18.9 113.3 i 21.2 
Respiratory rate (/min) 26.3 I 7.1 28.0 ? 8.5 
Leukocyte count (x103/mm3) 11.5 I 9.0 14.6 t 10.5 
Median 10 12.9 
Albumin (g/dL) 2.5 -f 0.7 2.9 t 0.7 
Lactate dehydrogenase (U/L) 439 -+ 364 416 1+ 330 
Median 317 314.5 
Arterial blood pH 7.41 t 0.07 7.37 t 0.13 
PaO,/FIO, (mm Hg) 291 2 104 250 i 114 
PaCO, (mm Hg) 30.1 ? 6.4 33.0 I 11.4 
Infiltrates on chest x-ray 
None 7 10 
Unilobar 21 43 
Multilobar 48 58 
P-Value 
0.0983* 
0.0549* 
0.6632* 
0.1365* 
0.0196+ 
0.0005* 
0.9838’ 
0.0443 
0.0215* 
0.0563 
0.2760t 
patients with AIDS and HIV-infected patients without 
AIDS.The leukocyte count (8.3 ? 5.4 X103/mm3 vs. 15.3 
2 10.9 X 103/mm3, median 7.6 vs. 11.7, P = 0.0020) and 
the serum albumin level (2.3 + 0.5 g/dL vs. 2.7 + 0.8 
g/dL, P = 0.0107) were lower in patients with AIDS than 
in HIV-infected patients without AIDS.The complication 
and ICU admission rates were similar for patients with 
AIDS and HIV-infected patients withoutAIDS.The median 
duration of hospital stay was 17 days for patients with 
AIDS compared to 11 days for HIV-infected patients with- 
out AIDS (P = 0.0204). Eleven (26%) of the 42 patients 
with AIDS died compared to 9 (24%) of the 37 HIV- 
infected patients without AIDS (P = 0.8490). The CD4 
count was available in 63 patients with HIV infection; 49 
survivors and 14 nonsurvivors. The median CD4 count 
was 23O/l~,L in survivors compared to 82/l~,L in nonsur- 
vivors (P = 0.1000). 
DISCUSSIONS 
Most of the opportunistic infections seen in patients with 
HIV infection are associated with a CD4+ T-lymphocyte 
count below 20O/l~,L. Humoral immune dysfunction, 
Table 3. Differences in Complication Rates 
between Patients with and without HIV Infection 
HIV Non-HIV 
n = 76 (%) n= Ill(%) P-Value 
Mechanical ventilator 23 (30) 49 (44) 0.0554* 
ARDS 8Ul) 11 (IO) 0.8910 
Empyema 1 (1) 4 (4) 0.64991 
Meningitis 5 (7) 5 (5) 0.5357* 
Seizure 1 (1) 5 (5) 0.4036+ 
Cardiac 1 (1) 12 (11) 0.0162’ 
Acute renal dysfunction 16 (21) 22 (20) 0.8370* 
Secondary infection 9 (12) 18 (16) 0.4032* 
Gastrointestinal bleeding 1 (1) 7 (6) 0.1450+ 
*Chi-square test; +Fisher’s exact test: ARDS = acute respiratory distress 
syndrome. 
depressed IgA2 and IgG2 levels, and decreased CD4 + T 
cell mediated antibody dependent cellular cytotoxicity are 
also present in HIV-infected patients and predispose them 
to pyogenic bacterial infections, including Streptococcus 
pneumoniae.“-8 Studies in Africa have shown that life- 
threatening bacteremia predominantly due to Salmonella 
species and S.pneumoniae are common in hospitalized 
HIV-l seropositive patients.9 Increased bacterial infections 
were described in the United States as early as the mid- 
1980~.~~-‘~ The incidence of pneumococcal bacteremia in 
AIDS patients is estimated to be 100 times higher than 
that reported in most community-based studies in the 
United States.3 In a retrospective study of 283 adults with 
sickle-cell disease over a Gyear period, pneumococcal bac- 
teremia was found in four of eight HIV-infected patients 
compared with 1 of 275 non-HIV-infected patients 
(P < 0.0001).13 Recognizing the importance of bacterial 
infections in patients with HIV infection, the CDC has 
added recurrent bacterial pneumonia as one of the AIDS- 
indicator conditions.5 
Although alcohol abuse has been found to be the 
most common risk factor for pneumococcal infection by 
many investigators, HIV infection has emerged as another 
common risk factor.r4 In one study from New York City, 
Table 4. Timing and Causes of Death 
following Pneumococcal Bacteremia 
H/V Non-HIV 
n = 20 n = 36 
Timing 
Within 24 hours 
Between 24 and 72 hours 
After 72 hours 
Causes 
Pneumococcal infection 
Secondary infection 
Others 
Not stated 
5 14 
4 2 
11 20 
15 26 
2 2 
1 5 
2 3 
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50% of the patients with pneumococcal bacteremia and 
pneumonia had HIV infection.15 In another study, from 
Spain, 72% of the patients under 40 years of age with 
pneumococcal pneumonia were HIV infected.16 Injection 
drug use, with or without HIV infection, is another risk 
factor for pneumococcal disease. 14z1’ Pneumococcal bac- 
teremia is more common inAfrican-Americans.1~18 Despite 
being a minority, the number of Black patients reported 
to have AIDS in the United States was equal to that of 
White patients in 1995.” Since Howard University Hos- 
pital serves predominantly an inner-city, African-Ameri- 
can population, the fmding that HIV infection was present 
in the majority of patients under 40 years of age is not 
surprising.The higher proportion of HIV-infected patients 
in the later years of the study most probably reflects the 
increasing prevalence of HIV infection. 
Although uncommon, recurrent episodes of pneu- 
mococcal bacteremia have been reported in immuno- 
compromised patients. 20-22 In the study by Redd and 
colleagues, the recurrence rate of invasive pneumococ- 
cal infection in HIV-infected patients was not significantly 
different from that in non-HIV-infected patients.’ In the 
present study, the recurrence rate of pneumococcal bac- 
teremia was higher in HIV-infected patients, although the 
difference was not statistically significant. 
In one study of community-acquired bacteremia in 
patients with AIDS, many patients presented with nor- 
mal vital signs, with only 57% of them being febrile on 
presentation. 23 In published studies of HIV-infected 
patients with pneumococcal infection, 73 to 86% of the 
patients had fever at presentation.*5:1G,24 In the present 
study, there was no statistically significant difference in 
vital signs between HIV-infected and non-infected 
patients. 
Leukopenia, hypoalbuminemia, elevated serum lac- 
tate dehydrogenase level, low arterial pH, low arterial 
oxygen tension, and high arterial oxygen tension have 
been shown to be associated with increased mortality in 
patients with pneumococcal bacteremia.* In the study by 
Krumholz et al of AIDS patients with pneumococcal bac- 
teremia, the mean WBC count was 4600/mm3 and 12 
(27%) of the 44 cases had leukocyte counts less than 
1000/mm3.23 However, five of these patients had recently 
received chemotherapy for malignancy, and two others 
had been on zidovudine. Janoff et al reported leukocyte 
counts less than 5OOO/pL in 44% and leukocytosis in 
19% of 16 HIV-infected homosexual men with pneumo- 
coccal bacteremia.24 Pesola and Charles found no dif- 
ference in leukocyte count between HIV-infected and 
non-HIV-infected patients.15 However, in the present 
study and the study by Garcia-Leoni et al, from Spain, 
the leukocyte count was lower in HIV-infected patients 
with pneumococcal infection compared to non-HIV- 
infected patientsI 
Pneumonia is the presenting manifestation of pneu- 
mococcal bacteremia in the majority of both HIV-infected 
and non-HIV-infected patients.3 Pesola and Charles found 
that AIDS patients with bacteremic pneumococcal pneu- 
monia were more likely to have bilateral infiltrates on 
chest roentgenograms than HIV-infected patients with- 
out AIDS and non-HIV-infected patients. l5 However, since 
some of their AIDS patients also had Pneumocystis 
carinii pneumonia, the radiologic findings do not reflect 
the sole effect of the pneumococcal infectionWhen com- 
parison was made between the non-AIDS HIV-infected 
and the non-HIV-infected patients in the Pesola and 
Charles study,lj the radiologic findings were identical. 
Similar to the study of Garcia-Leoni et aLI6 the present 
study did not find any significant radiologic differences 
between the HIV-infected and non-HIV-infected patients, 
despite higher arterial oxygen tension in the HIV-infected 
patients. 
The reported mortality rates of pneumococcal bac- 
teremia in HIV-infected patients without AIDS are low.3815 
In studies by Redd et al and Pesola and Charles, the mor- 
tality rate of HIV-infected patients without AIDS was 0 
compared to the 18% and 25% mortality rate of the 
non-HIV-infected patients. 3,15 However, the mortality rate 
of pneumococcal bacteremia in patients with AIDS has 
been shown to be as high as 25 to 57%.3,15 The overall 
mortality rate of pneumococcal bacteremia in HIV- 
infected patients in the present study was not signifi- 
cantly lower than that in non-HIV-infected patients. 
Although there are no uniform severity grading systems 
to compare different studies, the disease severity may 
explain the high mortality rate. In a previous study, we 
identified clinical and laboratory findings associated with 
poor outcome in patients with pneumococcal bac- 
teremia.* The good prognosis associated with younger 
age and higher arterial oxygen tension of the HIV-infected 
patients in the present study is counterbalanced by the 
lower leukocyte count and serum albumin levelThe over- 
all similarity in disease severity between HIV-infected and 
non-HIV-infected patients in the present study may 
explain the lack of differences in complication and mor- 
tality rates between the two groups. For HIV-infected 
patients without AIDS, the mortality rate was higher than 
the mortality rates reported in previous studies. 
Although in the present study, the pneumococcal 
vaccination rate was higher in patients with HIV infection 
than in those without HIV infection, it was unacceptably 
low in both groups. Since pneumococcal bacteremia is 
associated with high complication and mortality rates, 
more attention should be focused on prevention. The 
CDC recommends pneumococcal vaccine for patients 
with HIV infection.z5 Since HIV infected patients mount 
an appropriate antibody response to pneumococcal vac- 
cination,26-28 vaccine administration can be a cost-effec- 
tive prevention strategy.29 However, the development of 
pneumococcal bacteremia in ten patients with HIV infec- 
tion despite vaccination suggests that vaccination may 
be less effective in this population. 
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This study describes the differences between HIV- 
infected and non-HIV-infected patients with pneumo- 
coccal bacteremia. Human immunodeficiency virus 
infection has emerged as the most common risk factor for 
pneumococcal bacteremia in patients under 40 years of 
age. Based on findings by the authors and others, it is 
recommended that adults under 40 years of age with 
pneumococcal bacteremia should be evaluated for the 
presence of HTV infection. Although there were some 
clinical and laboratory differences between HIV-infected 
and non-HIV-infected patients with pneumococcal bac- 
teremia, the overall clinical course, including complication 
and mortality rates, were similar between the two groups. 
No significant differences in the hospital course was 
noted between AIDS patients and HKV-infected patients 
without AIDS with pneumococcal bacteremia. 
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